These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Beyond cholesterol. Inflammation is emerging as a major risk factor--and not just in heart disease. Park A Time; 2002 Nov; 160(22):74-5. PubMed ID: 12463072 [No Abstract] [Full Text] [Related]
5. C-reactive protein, cardiovascular disease and stroke: new roles for an old biomarker. Willcox BJ; Abbott RD; Yano K; Rodriguez BL; Willcox DC; Curb JD Expert Rev Neurother; 2004 May; 4(3):507-18. PubMed ID: 15853546 [TBL] [Abstract][Full Text] [Related]
6. C-reactive protein: a new risk assessment tool for cardiovascular disease. Clearfield MB J Am Osteopath Assoc; 2005 Sep; 105(9):409-16. PubMed ID: 16239491 [TBL] [Abstract][Full Text] [Related]
7. Use of a high-sensitivity C-reactive protein assay in evaluating cardiovascular disease risk. Luhr TA Am Clin Lab; 2000; 19(9):20-1. PubMed ID: 11193978 [No Abstract] [Full Text] [Related]
8. High sensitivity C-reactive protein and cardiovascular disease: an association built on unstable foundations? Sattar N; Lowe GD Ann Clin Biochem; 2006 Jul; 43(Pt 4):252-6. PubMed ID: 16824274 [TBL] [Abstract][Full Text] [Related]
10. C-reactive protein in cardiovascular risk prediction. Zooming in and zooming out. Maseri A Ital Heart J; 2001 Mar; 2(3):155-6. PubMed ID: 11305525 [No Abstract] [Full Text] [Related]
11. Additive value of immunoassay-measured fibrinogen and high-sensitivity C-reactive protein levels for predicting incident cardiovascular events. Mora S; Rifai N; Buring JE; Ridker PM Circulation; 2006 Aug; 114(5):381-7. PubMed ID: 16864722 [TBL] [Abstract][Full Text] [Related]
12. [C-reactive protein in cardiovascular diseases]. Lubas W; Gutkowski K Przegl Lek; 2006; 63(7):562-6. PubMed ID: 17203810 [TBL] [Abstract][Full Text] [Related]
13. C-reactive protein testing comes of age. Measuring low-grade inflammation can help refine cardiovascular risk. Harv Heart Lett; 2009 Feb; 19(6):2. PubMed ID: 19575518 [No Abstract] [Full Text] [Related]
14. [Inflammation and C-reactive protein in cardiovascular disease]. Munk PS; Larsen AI Tidsskr Nor Laegeforen; 2009 Jun; 129(12):1221-4. PubMed ID: 19521445 [TBL] [Abstract][Full Text] [Related]
15. Anti-inflammatory effects of pioglitazone and/or simvastatin in high cardiovascular risk patients with elevated high sensitivity C-reactive protein: the PIOSTAT Study. Hanefeld M; Marx N; Pfützner A; Baurecht W; Lübben G; Karagiannis E; Stier U; Forst T J Am Coll Cardiol; 2007 Jan; 49(3):290-7. PubMed ID: 17239709 [TBL] [Abstract][Full Text] [Related]
16. C-reactive protein: a nontraditional serum marker of cardiovascular risk. de Ferranti SD; Rifai N Cardiovasc Pathol; 2007; 16(1):14-21. PubMed ID: 17218210 [TBL] [Abstract][Full Text] [Related]
17. Health screening packages: the place of measuring C-reactive protein. Wong MS Singapore Med J; 2006 Oct; 47(10):827-9. PubMed ID: 16990955 [No Abstract] [Full Text] [Related]
18. C-reactive protein gene polymorphisms, C-reactive protein blood levels, and cardiovascular disease risk. Hage FG; Szalai AJ J Am Coll Cardiol; 2007 Sep; 50(12):1115-22. PubMed ID: 17868801 [TBL] [Abstract][Full Text] [Related]
19. [Inflammation study in unstable angina and myocardial infarction without ST segment elevation. Value of ultra-sensitive C-reactive protein]. Borrás Pallé S; Gómez Martínez E; Romero Rodrigo A; Campos Ferrer C; Molina E; Valentín Segura V An Med Interna; 2002 Jun; 19(6):283-8. PubMed ID: 12152386 [TBL] [Abstract][Full Text] [Related]
20. Role of hs-CRP measurements in the current cardiovascular risk assessment. García-Moll X; Ordóñez-Llanos J Clin Chim Acta; 2005 May; 355(1-2):215-8. PubMed ID: 15820499 [No Abstract] [Full Text] [Related] [Next] [New Search]